SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-16-000497
Filing Date
2016-04-01
Accepted
2016-03-31 17:33:14
Documents
3
Period of Report
2016-06-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER DATED MARCH 31, 2016 aurinia6knomrd.htm 6-K 5160
2 NOTICE OF MEETING AND RECORD DATE exhibit99-1.htm EX-99.1 4509
3 exhibit99-1x1x1.jpg GRAPHIC 5774
  Complete submission text file 0001176256-16-000497.txt   18753
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 161544253
SIC: 2834 Pharmaceutical Preparations